Recurrent candida prosthetic valve endocarditis following mitral valve replacement in hypertrophic obstructive cardiomyopathy

29 August 2026 (15:00 - 15:15)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Souna Boyadjian

Nork Marash Medical Center, Yerevan (Armenia)

3 More presentations in this session

Presentation thumbnail

Destructive prosthetic valve endocarditis after tavi complicated by cusp rupture and aorto–right atrial fistula

Miss D. Vasile (Bucharest, RO)

Presentation thumbnail

Long-term suppressive antimicrobial therapy guided by multimodality imaging in prosthetic mitral valve endocarditis due to Klebsiella pneumoniae in a non-surgical candidate

Doctor L. Di Vito (Ascoli Piceno, IT)

Presentation thumbnail

Unexpected Rhodotorula mucilaginosa co-infection revealed after surgery for destructive native aortic valve infective endocarditis with mitro-aortic pseudoaneurysm

Doctor I. Cristovao (Coimbra, PT)

Access the full session

Session thumbnail

Cases of prosthetic valve endocarditis: learning from experience

The Event

Event poster

ESC Congress 2026

29 August 2026 15:00 CET

You may be interested in

Congress Session

Personalised approach to decompensated heart failure

17 May 2025

Congress Presentation

Mitral regurgitation in obstructive hypertrophic cardiomyopathy: assessing the impact of mavacamten

13 December 2024

Congress Presentation

When calcification meets motion: mitral annular calcification and systolic anterior motion of the mitral valve driving heart failure in HOCM

9 May 2026

Webinar

The spectrum of management options for the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

28 October 2020

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources